Key result
The acute pressor effect of L-NAME (38 +/- 4 mm Hg increase in MAP) is mediated in part by cyclooxygenase-dependent products and endothelin, but not by the renin-angiotensin system.
Why the study?
What endogenous vasoactive systems mediate the pressor effect of acute L-NAME administration in anesthetized Wistar rats?
Population
Anesthetized Wistar rats
Comparison
Acute N omega-nitro-L-arginine methyl ester… vs Nonpretreated animals
Design
Preclinical
Follow-up
acute
Authors
Loading...
May guide targeted research on endothelin and prostaglandins in endothelial dysfunction; leaves open applicability to clinical hypertension.
What endogenous vasoactive systems mediate the pressor effect of acute L-NAME administration in anesthetized Wistar rats?
The acute pressor effect of L-NAME in rats is mediated partly by cyclooxygenase-dependent products and endothelin, but not by the renin-angiotensin system.
Nafrialdi et al. (1994) studied this question. N omega-nitro-L-arginine methyl ester (L-NAME) vs. Various pretreatments (losartan, enalapril, DOCA-salt, binephrectomy, low-sodium diet, prazosin, phosphoramidon, indomethacin, SQ 29548, nicardipine) was evaluated on Increase in mean arterial pressure (MAP). The acute pressor effect of L-NAME (38 +/- 4 mm Hg increase in MAP) is mediated in part by cyclooxygenase-dependent products and endothelin, but not by the renin-angiotensin system.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: